Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-24 @ 9:42 PM
NCT ID:
NCT01777932
Eligibility Criteria:
Inclusion Criteria:
* Patients with metastatic breast cancer initiated on first-line treatment with Avastin in combination with paclitaxel according to the current Hungarian summary of Product Characteristics
* Patients with metastatic breast cancer initiated within 6 months before the start of the study on treatment with Avastin according to the current Hungarian Summary of Product Characteristics
Exclusion Criteria:
Contraindications for Avastin according to the current Hungarian Summary of Product Characteristics:
* Hypersensitivity to active ingredient of Avastin or to any excipients
* Hypersensitivity to products produced in Chinese hamster cells or to other recombinant or humanized antibodies
* Pregnancy
* Untreated central nervous system metastases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01777932
Study Brief:
Protocol Section:
NCT01777932